---
title: "SINGHVI RAHUL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/20ecf098-ccda-57ef-a667-9d2dcb88b480
json: https://whiteintel.dev/api/public/dossier/20ecf098-ccda-57ef-a667-9d2dcb88b480
identifier: sec:0001322731
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SINGHVI RAHUL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001322731`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/20ecf098-ccda-57ef-a667-9d2dcb88b480  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/20ecf098-ccda-57ef-a667-9d2dcb88b480  

## Ownership & control

### Holdings / subsidiaries

- **NOVAVAX INC** (officer) — https://whiteintel.dev/entity/cf506ce1-283c-5b96-97da-db87bb748da6
- **NOVAVAX INC** (director) — https://whiteintel.dev/entity/cf506ce1-283c-5b96-97da-db87bb748da6
- **CODEXIS, INC.** (director) — https://whiteintel.dev/entity/4feca229-6d58-5434-a05f-05e76f36df57
- **Kairos Pharma, LTD.** (director) — https://whiteintel.dev/entity/38fab9e9-3f7b-5257-8675-466c5f225383
- **EOM PHARMACEUTICAL HOLDINGS, INC.** (director) — https://whiteintel.dev/entity/c5976c7a-58b8-5d2d-99a8-49fa53e80a0f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SINGHVI RAHUL**. Human view: https://whiteintel.dev/entity/20ecf098-ccda-57ef-a667-9d2dcb88b480 · Structured JSON: https://whiteintel.dev/api/public/dossier/20ecf098-ccda-57ef-a667-9d2dcb88b480._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._